Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: GKOS

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

JP Morgan Upgrades Glaukos to Neutral, Lowers Price Target to $42

By Benzinga Newsdesk
December 19, 6:50 AM
JP Morgan analyst Allen Gong upgrades Glaukos (NYSE:GKOS) from Underweight to Neutral and lowers the price target from $48 to $42.

GKOS

Read More
1 minute read
  • Analyst Ratings

7 Analysts Have This to Say About Glaukos

By Benzinga Insights
December 12, 3:02 PM
Glaukos (NYSE:GKOS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

GKOS

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Wells Fargo Maintains Equal-Weight on Glaukos, Lowers Price Target to $44

By Benzinga Newsdesk
December 12, 11:18 AM
Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:GKOS) with a Equal-Weight and lowers the price target from $56 to $44.

GKOS

Read More
15 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022

By Benzinga Insights
December 12, 11:01 AM
Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…

ACHC

Read More
3 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday

By Lisa Levin
November 4, 6:06 AM
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.

ATUS

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Needham Maintains Buy on Glaukos, Lowers Price Target to $65

By Benzinga Newsdesk
November 3, 5:22 AM
Needham analyst David Saxon maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $66 to $65.

GKOS

Read More
1 minute read
  • Earnings
  • News

Glaukos Q3 EPS $(0.45) Beats $(0.52) Estimate, Sales $71.30M Beat $67.94M Estimate

By Benzinga Newsdesk
November 2, 4:29 PM
Glaukos (NYSE:GKOS) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.52) by 13.46 percent. This is a 114.29 percent decrease over losses of $(0.21) per share from the same

GKOS

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Stephens & Co. Reinstates Overweight on Glaukos, Announces $69 Price Target

By Benzinga Newsdesk
October 14, 5:21 AM
Stephens & Co. analyst George Sellers reinstates Glaukos (NYSE:GKOS) with a Overweight and announces $69 price target.

GKOS

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Initiation
  • News
  • Price Target

Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock

By Vandana Singh
October 4, 2:27 PM
Needham initiated coverage on Glaukos Corp (NYSE:GKOS) with a price target of $66 and a Buy rating. The analyst writes that GKOS has…

GKOS

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Needham Initiates Coverage On Glaukos with Buy Rating, Announces Price Target of $66

By Benzinga Newsdesk
October 4, 6:05 AM
Needham analyst David Saxon initiates coverage on Glaukos (NYSE:GKOS) with a Buy rating and announces Price Target of $66.

GKOS

Posts pagination

Previous 1 … 4 5 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service